InVivo Therapeutics reports narrowed annual losses, due in part to changes in the market value of the company's derivative warrant liability.
(OTC:IVOB) reported a narrowed annual loss, due in part to changes in the market value of the company's derivative warrant liability.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1LjPaiD
Cap comentari:
Publica un comentari a l'entrada